Percentage of patients, age = 18 and < 80 at diagnosis, who have their first diagnosis of cancer (epithelial malignancy) that is lymph node positive and at AJCC stage III, whose primary tumor is of the colon and chemotherapy was recommended or administered within 4 months (120 days) of diagnosis
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Adjuvant chemotherapy is administered within 4 months (120 days) of the date of diagnosis or it is recommended but not administered
DenominatorInclude if all of the following characteristics are identified:
Men or Women
Age = 18 and < 80 at time of diagnosis
Known or assumed to be first or only cancer diagnosis
Epithelial malignancy only
Invasive tumors
Primary tumors of the colon
All or part of 1st course of treatment performed at the reporting facility
Known to be alive within 4 months (120 days) of date of diagnosis
Lymph node positive disease
Surgical procedure of the primary siteExclusionsExclude, if any of the following characteristics are identified:
Under age 18 or over age 80 at time of diagnosis
Second or subsequent cancer diagnosis
Tumor not originating in the colon
Non-epithelial malignancies
Non-invasive tumors
Stage 0, in situ tumor
Stage IV, metastatic tumor
None of 1st course therapy performed at reporting facility
Died within 4 months (120 days) of diagnosis
Not lymph node positive disease
Patient enrolled in a clinical trial that directly impacts delivery of the standard of care
No surgical procedure of the primary siteTesting Data Sources
- Measure StructureClinical Condition Topic AreaNon Condition SpecificTarget PopulationMeasure Selection AttributesNational Quality Strategy PrioritiesEffective Communication and Care Coordination
- Risk Adjustment
- Current or planned use(s)Current Use(s)Use In Federal Program
- Most Recent Endorsement ActivityEndorsed Cancer Fall Cycle 2019Initial EndorsementNext Planned Maintenance ReviewCancer Fall 2023Endorsement StatusLast Updated
- StewardSteward Organization Email